SIX1 and breast carcinoma: In addition to the role of Six1 in the early development, it is often misexpressed in various tumors such as breast cancer [5], [11], Wilms’ tumors [12], rhabdomyosarcomas [13], hepatocellular carcinoma [14], ovarian cancer [15], [16], and cervical cancer [17], [18].